Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
612
-
Total 13F shares, excl. options
-
100,513,676
-
Shares change
-
-1,610,622
-
Total reported value, excl. options
-
$17,230,325,953
-
Value change
-
-$286,391,481
-
Put/Call ratio
-
139%
-
Number of buys
-
291
-
Number of sells
-
-271
-
Price
-
$171.43
Significant Holders of RESMED INC - Common Stock (RMD) as of Q3 2020
691 filings reported holding RMD - RESMED INC - Common Stock as of Q3 2020.
RESMED INC - Common Stock (RMD) has 612 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100,513,676 shares
of 146,467,184 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15,644,513 shares), BlackRock Inc. (13,281,481 shares), WCM INVESTMENT MANAGEMENT, LLC (8,690,493 shares), STATE STREET CORP (6,594,878 shares), Capital World Investors (5,338,434 shares), FMR LLC (4,696,482 shares), BAILLIE GIFFORD & CO (3,133,368 shares), GEODE CAPITAL MANAGEMENT, LLC (2,475,531 shares), Invesco Ltd. (2,282,977 shares), and NORTHERN TRUST CORP (2,250,053 shares).
This table shows the top 612 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.